Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
6.21
+0.07 (1.14%)
At close: Aug 13, 2025, 4:00 PM
6.25
+0.04 (0.64%)
After-hours: Aug 13, 2025, 4:37 PM EDT
DAWN Stock Forecast
Stock Price Forecast
The 7 analysts that cover DAWN stock have a consensus rating of "Strong Buy" and an average price target of $27.86, which forecasts a 348.63% increase in the stock price over the next year. The lowest target is $16 and the highest is $36.
Price Target: $27.86 (+348.63%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DAWN stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $36 → $25 | Strong Buy | Maintains | $36 → $25 | +302.58% | Aug 6, 2025 |
| Needham | Needham | Strong Buy Maintains $18 → $16 | Strong Buy | Maintains | $18 → $16 | +157.65% | Aug 6, 2025 |
| Needham | Needham | Strong Buy Maintains $30 → $27 | Strong Buy | Maintains | $30 → $27 | +334.78% | May 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +479.71% | Apr 3, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $39 → $27 | Strong Buy | Maintains | $39 → $27 | +334.78% | Mar 25, 2025 |
Financial Forecast
Revenue This Year
152.70M
from 131.16M
Increased by 16.42%
Revenue Next Year
225.27M
from 152.70M
Increased by 47.52%
EPS This Year
-1.41
from -1.02
EPS Next Year
-0.85
from -1.41
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 169.0M | 309.3M | 477.8M | ||
| Avg | 152.7M | 225.3M | 376.9M | ||
| Low | 136.2M | 167.7M | 255.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 28.9% | 102.6% | 112.1% | ||
| Avg | 16.4% | 47.5% | 67.3% | ||
| Low | 3.9% | 9.8% | 13.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.21 | -0.16 | 0.68 | ||
| Avg | -1.41 | -0.85 | 0.24 | ||
| Low | -1.51 | -1.62 | -0.13 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.